Allogeneic Cell Therapy Innovations
We discussed the potential of allogeneic therapies across oncology and non-oncology and featured insights on leading developers, therapeutic classes, and current targets. Additionally, our industry experts provided an overview of clinical market trends, regulatory landscapes, and strategic considerations to help stakeholders make informed decisions. Watch the recording now.

Our Experts

Rachel East
House Speaker
Senior Research Analyst
Beacon

Ahmed Tajmohamed
House Speaker
Market Analyst
Hanson Wade Intelligence

Thomas Vickers
Moderator
Account Manager
Beacon
You May Also Be Interested In…
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
Access WebinarWhat is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements